Research
-
Does the risk of breast cancer vary with different combinations of hormone replacement therapy?
August 22, 2010 -
Ixabepilone plus capecitabine vs. capecitabine in metastatic breast cancer patients
July 14, 2010 -
Advocate Analysis: The quality of breast cancer care provided by the California BCCTP to uninsured women
July 13, 2010 -
Phase II study of PARP Inhibitor olaparib for women with BRCA 1- or BRCA2-mutated advanced breast cancer
July 11, 2010 -
Body fatness at a young age and lifetime breast cancer risk
July 9, 2010 -
Erythropoiesis-stimulating agents (ESAs) in breast cancer
July 1, 2010 -
A lack of adherence and completion of adjuvant hormonal therapy: Why?
June 29, 2010 -
Factor V Leiden mutation, thromboembolism risk, and tamoxifen
June 28, 2010 -
Gene Expression Profiling for Breast Cancer: What is it and how is it used?
June 25, 2010 -
Can bisphosphonates reduce the risk of postmenopausal breast cancer?
June 24, 2010
Understanding Research and Evidence